Current clinical evidence on pioglitazone pharmacogenomics

por Kawaguchi-Suzuki, Marina, Frye, Reginald F.
Publicado 2013

A Genetic Score Associates With Pioglitazone Response in Patients With Non-alcoholic Steatohepatitis

por Kawaguchi-Suzuki, Marina, Cusi, Kenneth, Bril, Fernando, Gong, Yan, Langaee, Taimour, Frye, Reginald F.
Publicado 2018

The Tokyo 2020 Olympic and Paralympic pharmacy services during the COVID-19 pandemic

por Kasashi, Kumiko, Sato, Ayaka, Stuart, Mark, Hollywood, Úna, Kawaguchi-Suzuki, Marina, Yagishita, Kazuyoshi, Akama, Takao
Publicado 2023

Characteristics of Successful International Pharmacy Partnerships

por Prescott, Gina M., Jonkman, Lauren, Crutchley, Rustin D., Dey, Surajit, Hong, Lisa T., Malhotra, Jodie, Seo, See-Won, Kawaguchi-Suzuki, Marina, Truong, Hoai-An, Unni, Elizabeth, Tsuchihashi, Kayo, Forkan, Nubaira, Abrons, Jeanine P.
Publicado 2023

Atenolol Induced HDL-C Change in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) Study

por McDonough, Caitrin W., Gillis, Nancy K., Alsultan, Abdullah, Chang, Shin-Wen, Kawaguchi-Suzuki, Marina, Lang, Jason E., Shahin, Mohamed Hossam A., Buford, Thomas W., El Rouby, Nihal M., Sá, Ana C.C., Langaee, Taimour Y., Gums, John G., Chapman, Arlene B., Cooper-DeHoff, Rhonda M., Turner, Stephen T., Gong, Yan, Johnson, Julie A.
Publicado 2013